Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Targeting TGF- signaling to alleviate obesity Despite significant advances in understanding the role of the TGF- pathway in obesity, obesity-induced diseases, and cancer, critical questions remain about whether this pathway functions predominantly as a driver or suppressor in these conditions
How it works Semaglutide aids weight loss by activating GLP-1 receptors in the brain, which reduces appetite and promotes feelings of fullness.* Additionally, it slows down gastric emptying, delaying the absorption of glucose from food and contributing to lower calorie intake
The clinical benefit is at or near its maximum
doi: 10.3389/fimmu.2021.734229 133 ZhuFXiongFHeJLiuKYouYXuQet al
US$ 21.11
US$ 29.68
US$ 27.46
US$ 27.87
